Morgan Stanley Direct Lending Fund’s recent filing unveils that its Director Shannon Kevin acquired Company’s shares for reported $88500.0 on Aug 14 ’25. In the deal valued at $17.70 per share,5,000 shares were bought. As a result of this transaction, Shannon Kevin now holds 29,079 shares worth roughly $0.51 million.
Then, Pessah David bought 3,400 shares, generating $60,254 in total proceeds. Upon buying the shares at $17.72, the Chief Financial Officer now owns 5,400 shares.
Before that, Metz Adam S bought 28,248 shares. Morgan Stanley Direct Lending Fund shares valued at $499,122 were divested by the Director at a price of $17.67 per share. As a result of the transaction, Metz Adam S now holds 28,248 shares, worth roughly $0.5 million.
UBS downgraded its Morgan Stanley Direct Lending Fund [MSDL] rating to a Neutral from a a Buy in a research note published recently. A number of analysts have revised their coverage, including Raymond James’s analysts, who decreased its forecast for the stock in mid May from “an Outperform” to “a Mkt perform”. Wells Fargo began covering MSDL with “an Equal weight” recommendation on February 20, 2024. UBS started covering the stock on February 20, 2024. It rated MSDL as “a Buy”.
Price Performance Review of MSDL
On Monday, Morgan Stanley Direct Lending Fund [NYSE:MSDL] saw its stock fall -1.24% to $17.55. Over the last five days, the stock has lost -2.45%. Morgan Stanley Direct Lending Fund shares have fallen nearly -11.90% since the year began. Nevertheless, the stocks have fallen -15.05% over the past one year.
How much short interest is there in Morgan Stanley Direct Lending Fund?
A steep rise in short interest was recorded in Morgan Stanley Direct Lending Fund stocks on 2025-08-29, growing by 0.2 million shares to a total of 0.39 million shares. Yahoo Finance data shows the prior-month short interest on 2025-07-31 was 0.19 million shares. There was a rise of 51.64%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on February 20, 2024 when RBC Capital Mkts began covering the stock and recommended ‘”an Outperform”‘ rating along with a $21 price target.
